Advion Opens Midwest Center of Excellence

Advion BioServices, a subsidiary of Advion BioSciences, Inc., has opened its new 22,000-sq.-ft. Drug Discovery and Metabolism bioanalytical lab in Indianapolis, IN. This expansion was in response to increased demand for metabolism, ADME screening and other early-stage bioanalytical services, as well as to build upon local partnership in the Indianapolis area.

The new facility will focus on the earlier stage, drug discovery and metabolism bioanalytical services required for the preparation of a molecule’s entry into clinical testing. The site is located in the Purdue Research Park of Indianapolis’ technology center at the Ameriplex Business Park, and has approximately 50 employees.

“For our existing clients, the additional services offer a broader and more comprehensive approach to utilize early-access scientific knowledge and transfer this to later stage analysis,” said David B. Patteson, Advion’s president and chief executive officer. “This should allow us to offer what the clients want, when they need it, while ensuring the scientific integrity and quality are maintained at Advion’s high standards.”